Proteomic profiling identifies specific histone species associated with leukemic and cancer cells.
CONCLUSIONS: Signatures of histone profiles are complex and can distinguish between healthy individuals and CLL patients and may provide prognostic markers. In addition, histone profiles may define tissue specific malignancies.
PMID: 26321891 [PubMed]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Singh R, Harshman SW, Ruppert AS, Mortazavi A, Lucas DM, Thomas-Ahner JM, Clinton SK, Byrd JC, Freitas MA, Parthun MR Tags: Clin Proteomics Source Type: research
More News: Bladder Cancer | Breast Cancer | Cancer | Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Leukemia